Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor

Haemophilia

Volumn 4, Issue 5, 1998, Pages 762-765

  Montoro, J B ^a   Altisent, C ^a   Pico, M ^a   Cabanas M J ^b   Vila, M ^a   Puig, L L ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; CLINICAL FEATURE; CONTINUOUS INFUSION; HEALTH CARE COST; HEMOPHILIA A; HEMOSTASIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIPUMP; PRESCHOOL CHILD; PRIORITY JOURNAL; TIME; WOUND HEALING;

AUTOANTIBODIES; CATHETERIZATION, CENTRAL VENOUS; CHILD; FACTOR VIIA; FACTOR VIII; HEMOSTATICS; HUMANS; INFUSION PUMPS; MALE; RECOMBINANT PROTEINS; TITRIMETRY;

EID: 0031688360     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.00186.x     Document Type: Article

References (10)

1. Hedner U, Glazer S, Pingel K, Alberts KA, Blombäck Schulman S, Johnsson H. Succesful use of recombinant factor Vila in a patient with severe haemophilia A during sinovectomy. Lancet 1988; 2: 1193.
2. Macik BG, Lindley CM, Lusher J, Sawyer WT, Bloom AL. Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study. Blood Coagulation Fibrinolysis 1993; 4: 521-7.
3. Broze G, Majerus PT. Human factor VII. Meth Enzymol 1981; 10: 228-37.
4. Lindley CM, Sawyer WT, Macik BG, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994; 55: 638-48.
5. Rodriguez-Bueno S, Montoro JB, Martinez B, Altisent C, Tusell JM. Administración de concentrados de factor VIII a hemofilicos mediante bomba de perfusion continua. Med Clin (Barc) 1991; 96: 364-6.
6. Martinowitz U, Schulman S, Gitel S, Horoszowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
7. Schulman S, Bech-Jensen M, Varon D, et al. Feasibility of using recombinant factor Vila in continuous infusion. Thromb Haemost 1996; 75: 432-6.
8. Smith OP, Hann IM. RFVIIa therapy to secure haemostasis during central line insertion in children with highresponding FVIII inhibitors. Br J Haematol 1996; 92: 1002-4.
9. DiMichele D. The use of recombinant factor Vila for central catheter insertion: an international experience. XVI Congress of ISTH, Florence, 1997; SC679.
10. Cooper HA, Gilchrist GS, Hoots WK, Shapiro A. Comparison of two doses of recombinant factor Vila (rFVIIa) for producing hemostasis during and after surgery in patients (pts) with hemophilia A or B and inhibitors and pts with adquired inhibitors. XVI Congress of ISTH, Florence, 1997; SC680.